Diagnostic Biomarkers in Metabolomics

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. A biomarker reveals further information to presently existing clinical and pathological analysis. It facilitates screening and detecting the disease, monitoring the progression of the disease, and predicting the diagnosis and survival after clinical intervention. A biomarker can also be used to evaluate the process of drug development and optimally to improve the efficacy and safety of disease treatment by enabling physicians to tailor treatment for individual patients. These emerging biomarkers will be beneficial and critical in developing new and clinically reliable indicators that will have a high specificity for the diagnosis.

  • Metabolite platform for validation of biomarkers
  • Biomarkers in drug development
  • Disease related biomarkers
  • Imaging biomarkers
  • Metabolomics in biomarker discovery

Related Conference of Diagnostic Biomarkers in Metabolomics

December 10-11, 2020

2nd Pathology and Infectious Disease Conference

Dubai, UAE
March 18-19, 2021

12th Tissue Repair and Regeneration Congress

Abu Dhabi, UAE
March 28-29, 2021

11th Glycobiology World Congress

Vienna, Austria
June 11-12, 2021

25th Global Congress on Biotechnology

Berlin, Germany
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland

Diagnostic Biomarkers in Metabolomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in